{"product_id":"immunotherapy-in-translational-cancer-research-isbn-9781118123225","title":"Immunotherapy in Translational Cancer Research","description":"\u003cp\u003e\u003cb\u003eA guide to state-of-the-art cancer immunotherapy in translational cancer research\u003c\/b\u003e\u003cb\u003e \u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eA volume in the \u003ci\u003eTranslational Oncology\u003c\/i\u003e series, \u003ci\u003eImmunotherapy in Translational Cancer Research\u003c\/i\u003e explores the recent developments in the role that immunotherapy plays in the treatment of a wide range of cancers. The editors present key concepts, illustrative examples, and suggest alternative strategies in order to achieve individualized targeted therapy. Comprehensive in scope, \u003ci\u003eImmunotherapy in Translational Cancer Research\u003c\/i\u003e reviews the relevant history, current state, and the future of burgeoning cancer-fighting therapies. The book also includes critical information on drug development, clinical trials, and governmental resources and regulatory issues.\u003c\/p\u003e \u003cp\u003eEach chapter is created to feature: development of the immunotherapy; challenges that have been overcome in order to scale up and undertake clinical trials; and clinical experience and application of research. This authoritative volume is edited by a team of noted experts from MD Anderson Cancer Center, the world’s foremost cancer research and care center and: \u003c\/p\u003e \u003cul\u003e \u003cli\u003eOffers a comprehensive presentation of state-of-the-art cancer immunotherapy research that accelerates the pace of clinical cancer care \u003c\/li\u003e \u003cli\u003eFilled with the concepts, examples, and approaches for developing individualized therapy\u003c\/li\u003e \u003cli\u003eExplores the breath of treatments that reflect the complexity of the immune system itself\u003c\/li\u003e \u003cli\u003eIncludes contributions from a panel international experts in the field of immunotherapy\u003c\/li\u003e \u003c\/ul\u003e \u003cp\u003eDesigned for physicians, medical students, scientists, pharmaceutical executives, public health and public policy government leaders and community oncologists, this essential resource offers a guide to the bidirectional interaction between laboratory and clinic immunotherapy cancer research.\u003c\/p\u003e \u003cp\u003eEditors vi\u003c\/p\u003e \u003cp\u003eContributors vii\u003c\/p\u003e \u003cp\u003eIntroduction ix\u003c\/p\u003e \u003cp\u003e1 Translation in Immunology: The Role of Translational Biomarkers to Guide Clinical Use of Immunotherapy for Cancer 1\u003cbr\u003e\u003ci\u003eSaranya Chumsri and Keith L. Knutson\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e2 Monoclonal Antibody Therapy 12\u003cbr\u003e\u003ci\u003eElizabeth A. Mittendorf and Sabitha Prabhakaran\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e3 Somatic Mutations and Immunotherapy 24\u003cbr\u003e\u003ci\u003eEric Tran\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e4 Checkpoint Blockade 37\u003cbr\u003e\u003ci\u003eTracy A. Proverbs‐Singh Jedd Wolchok and Alexandra Snyder\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e5 Myeloid Leukemia Vaccines 54\u003cbr\u003e\u003ci\u003ePaul M. Armistead and Jonathan S. Serody\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e6 Cancer Vaccines for Solid Tumors 72\u003cbr\u003e\u003ci\u003eTimothy J. Vreeland Garth S. Herbert and George E. Peoples\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e7 Immunotherapy with Non–Genetically Modified T Cells 91\u003cbr\u003e\u003ci\u003eCassian Yee\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e8 Immunotherapy with Genetically Modified T Cells 101\u003cbr\u003e\u003ci\u003eLiora Schultz and Crystal Mackall\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e9 Immunomodulation with Adjuvants and Cytokines 115\u003cbr\u003e\u003ci\u003eDae won Kim and Adi Diab\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e10 Immune Cell Migration in Cancer and Immunotherapy 132\u003cbr\u003e\u003ci\u003eTimothy Murray and Daniel E. Speiser\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e11 Repurposing of Drugs for Immunotherapy 143\u003cbr\u003e\u003ci\u003eJyothishmathi Swaminathan and Vidya Gopalakrishnan\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e12 Immunomodulation with Radiation 161\u003cbr\u003e\u003ci\u003eJonathan E. Schoenhals Taylor R. Cushman, Alexandra P. Cadena Sandra Demaria and James W. Welsh\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e13 Good Manufacturing Practices Facilities for Cellular Therapy 177\u003cbr\u003e\u003ci\u003eAndrew D. Fesnak and Bruce L. Levine\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e14 T Cell Receptor Mimic Antibodies 186\u003cbr\u003e\u003ci\u003eGheath Alatrash and Jeffrey J. Molldrem\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e15 Stem Cell Transplantation for Treatment of Malignancy 201\u003cbr\u003e\u003ci\u003eLohith S. Bachegowda and Richard E. Champlin\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e16 Natural Killer Cell–Based Immunotherapy 215\u003cbr\u003e\u003ci\u003eJennifer A. Foltz Jeffrey S. Miller and Dean A. Lee\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e17 Immunologic Monitoring in Immuno‐Oncology 228\u003cbr\u003e\u003ci\u003eWilliam R. Gwin and Mary L. Disis\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e18 Cell‐Based Therapies for Canine Cancer 252\u003cbr\u003e\u003ci\u003eNicola J. Mason and M. Kazim Panjwani\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e19 Interaction between Targeted Therapy and Immunotherapy 268\u003cbr\u003e\u003ci\u003ePeter A. Prieto Miles C. Andrews, Alexandria P. Cogdill, and Jennifer A. Wargo\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIndex 286\u003c\/p\u003e   \u003cp\u003e \u003cstrong\u003eLaurence J. N. Cooper,\u003c\/strong\u003e Associate Professor, Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, USA.  \u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eElizabeth A. Mittendorf,\u003c\/strong\u003e Professor, Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.   \u003c\/p\u003e\u003cp\u003e\u003cstrong\u003e\u003cstrong\u003eJudy Moyes,\u003c\/strong\u003e\u003c\/strong\u003e Department of Pediatric Research, The University of Texas MD Anderson Cancer Center, Houston, USA.  \u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eSabitha Prabhakaran,\u003c\/strong\u003e Clinical Research Scientist, Department of Breast Surgical Oncology,  The University of Texas MD Anderson Cancer Center, Houston, USA.     \u003c\/p\u003e\u003cp\u003e \u003cstrong\u003eA guide to state-of-the-art cancer immunotherapy in translational cancer research\u003c\/strong\u003e   \u003c\/p\u003e\u003cp\u003e A volume in the Translational Oncology series, \u003cem\u003eImmunotherapy in Translational Cancer Research\u003c\/em\u003e explores the recent developments in the role that immunotherapy plays in the treatment of a wide range of cancers. The editors present key concepts, illustrative examples, and suggest alternative strategies in order to achieve individualized targeted therapy. Comprehensive in scope, \u003cem\u003eImmunotherapy in Translational Cancer Research\u003c\/em\u003e reviews the relevant history, current state, and the future of burgeoning cancer-fighting therapies. The book also includes critical information on drug development,  clinical trials, and governmental resources and regulatory issues.    \u003c\/p\u003e\u003cp\u003e Each chapter is created to feature: development of the immunotherapy; challenges that have been overcome in order to scale up and undertake clinical trials; and clinical experience and application of research. This authoritative volume is edited by a team of noted experts from MD Anderson Cancer Center, the world???s foremost cancer research and care center and:   \u003c\/p\u003e\u003cul\u003e \u003cli\u003eOffers a comprehensive presentation of state-of-the-art cancer immunotherapy research that accelerates the pace of clinical cancer care\u003c\/li\u003e \u003cli\u003eFilled with the concepts, examples, and approaches for developing individualized therapy\u003c\/li\u003e \u003cli\u003eExplores the breath of treatments that reflect the complexity of the immune system itself\u003c\/li\u003e \u003cli\u003eIncludes contributions from a panel international experts in the field of immunotherapy\u003c\/li\u003e \u003c\/ul\u003e \u003cbr\u003e  \u003cp\u003e Designed for physicians, medical students, scientists, pharmaceutical executives, public health and public policy government leaders and community oncologists, this essential resource offers a guide to the bidirectional interaction between laboratory and clinic immunotherapy cancer research\u003c\/p\u003e","brand":"Wiley-Blackwell","offers":[{"title":"Default Title","offer_id":47989404041445,"sku":"NP9781118123225","price":214.95,"currency_code":"USD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1842\/7735\/files\/9781118123225.jpg?v=1761783978","url":"https:\/\/k12savings.com\/es\/products\/immunotherapy-in-translational-cancer-research-isbn-9781118123225","provider":"K12savings","version":"1.0","type":"link"}